Small-cell lung cancer (SCLC) is an aggressive malignancy characterized by a rapid
progression and a high resistance to treatments. Unlike other solid tumors, there has been a …

Purpose This study aimed to provide the clinical characteristics, prognostic factors, and 5-
year relative survival rates of lung cancer diagnosed in 2015. Materials and Methods The …

Glycoprotein nonmetastatic melanoma B (GPNMB) is a type I transmembrane glycoprotein
which is overexpressed in many tumors and seems to play a critical role in metastasis of …

Introduction Accurate, individualized prognostication for lung cancer patients requires the
integration of standard patient and pathologic factors, biological, genetic, and other …

Objectives Small cell lung cancer (SCLC) can be subgrouped into central and peripheral
types according to the location of the primary lesion. However, the clinical differences …

Objective The purpose of this study was to assess whether thoracic radiotherapy (TRT)
combined with chemotherapy (CHT) showed promising anti-tumour activity in extensive …

Background It is not clear whether or not the fate of patients suffering from small-cell lung
cancer (SCLC) has improved. To better understand the course of disease, we aimed at …

Background and Aims Small cell lung cancer (SCLC) is frequently associated with syndrome
of inappropriate antidiuretic hormone (SIADH) secretion. In this study we investigated the …

Background Small-cell lung cancer (SCLC) is responsive to initial chemotherapy but
becomes resistant to cytotoxic drugs. The aim of this study was to evaluate what proportion …

Aims M yc family members are important contributors to oncogenesis in a variety of tumours.
Identification of therapeutic targets is needed in small‐cell lung carcinoma (SCLC), an …